Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors-Reference-Cited by-同舟云学术

Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors

Published:2024-04-08 Issue:4 Volume:26 Page:429-440
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Minichmayr Iris K.^ORCID,Knaack Ursula,Gojo Johannes^ORCID,Senfter Daniel^ORCID,Haberler Christine^ORCID,Azizi Amedeo A.^ORCID,Mayr Lisa^ORCID,Zeitlinger Markus^ORCID,Peyrl Andreas^ORCID

Funder

Forschungsgesellschaft für Cerebrale Tumore

Medical University of Vienna

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40272-024-00624-y.pdf

Reference54 articles.

1. Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro-Oncology. 2023;25:iv1-99. https://doi.org/10.1093/neuonc/noad149.

2. Cohen AR. Brain tumors in children. N Engl J Med. 2022;386:1922–31. https://doi.org/10.1056/NEJMra2116344.

3. Kaschka WP, Theilkaes L, Eickhoff K, Skvaril F. Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis. Infect Immun. 1979;26:933–41.

4. Petereit H, Rubbert-Roth A. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders. Mult Scler. 2009;15:189–92. https://doi.org/10.1177/1352458508098268.

5. Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101:466–8. https://doi.org/10.1182/blood-2002-06-1636.